Published in Acta Derm Venereol on January 01, 2005
Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol (2014) 1.52
Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review. Arch Med Sci (2012) 0.78
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors. Drugs Real World Outcomes (2016) 0.75
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol (2007) 2.59
Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol (2011) 2.45
Polidocanol concentration and time affect the properties of foam used for sclerotherapy. Dermatol Surg (2011) 2.03
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol (2012) 1.93
How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. J Invest Dermatol (2009) 1.87
Heat conduction from the exceedingly hot fiber tip contributes to the endovenous laser ablation of varicose veins. Lasers Med Sci (2009) 1.69
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study. Arch Dermatol (2011) 1.66
Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study. J Invest Dermatol (2006) 1.57
Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg (2008) 1.51
Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins. J Vasc Surg (2011) 1.47
Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy. Melanoma Res (2009) 1.43
Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol (2010) 1.42
[Basal cell carcinoma: often more than one]. Ned Tijdschr Geneeskd (2011) 1.39
Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. J Invest Dermatol (2013) 1.39
Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol (2010) 1.24
Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg (2009) 1.17
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol (2009) 1.11
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer (2014) 1.10
Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol (2012) 1.07
Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol (2011) 1.06
Pyoderma gangrenosum: a challenging complication of bilateral mastopexy. Int Wound J (2004) 1.06
Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer (2013) 1.02
Risk factors for single and multiple basal cell carcinomas. Arch Dermatol (2010) 1.01
Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol (2013) 0.99
Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol (2009) 0.98
Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg (2013) 0.98
Carbonized blood deposited on fibres during 810, 940 and 1,470 nm endovenous laser ablation: thickness and absorption by optical coherence tomography. Lasers Med Sci (2010) 0.97
Familial aggregation of alopecia areata. J Am Acad Dermatol (2006) 0.96
Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans. Hum Genet (2012) 0.95
European guideline on chronic pruritus. Acta Derm Venereol (2012) 0.92
A case of long-lasting localized pemphigus vulgaris of the scalp. Dermatology (2004) 0.91
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire. JAMA Dermatol (2013) 0.90
Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort. J Am Acad Dermatol (2011) 0.90
Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res (2010) 0.89
Investigation of the HLA-DRB1 locus in alopecia areata. Eur J Dermatol (2006) 0.89
The heat-pipe resembling action of boiling bubbles in endovenous laser ablation. Lasers Med Sci (2010) 0.89
High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer (2010) 0.89
Duplication of the great saphenous vein: a definition problem and implications for therapy. Dermatol Surg (2011) 0.89
Optical-thermal mathematical model for endovenous laser ablation of varicose veins. Lasers Med Sci (2013) 0.87
Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol (2007) 0.86
Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer (2009) 0.84
Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study. Acta Derm Venereol (2009) 0.84
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. J Cutan Pathol (2005) 0.84
Patient advocacy groups: let's stick together. J Invest Dermatol (2010) 0.83
Socio-economic implications of cancer survivorship: results from the PROFILES registry. Eur J Cancer (2011) 0.83
Dimensionality of the dermatology life quality index (DLQI): a commentary. Acta Derm Venereol (2006) 0.83
Population education in preventing skin cancer: from childhood to adulthood. J Drugs Dermatol (2010) 0.83
A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO). Eur J Dermatol (2012) 0.82
Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev (2010) 0.81
A sudden flare-up of a quiescent oral lichen planus: methylisothiazolinone as the prime suspect? Contact Dermatitis (2015) 0.81
Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Exp Dermatol (2010) 0.81
Comorbidities in dermatology. Dermatol Clin (2009) 0.81
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Med Res Methodol (2012) 0.81
Cutaneous leishmaniasis: treatment with low-dose oral fluconazole with an excellent cosmetic result. Pediatr Dermatol (2014) 0.80
Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users. Int J Cancer (2013) 0.79
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med (2014) 0.79
Lower lifetime prevalence of atopy in rheumatoid arthritis. Rheumatol Int (2013) 0.79
Dermatologic signs of biotin deficiency leading to the diagnosis of multiple carboxylase deficiency. Pediatr Dermatol (2004) 0.79
Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris. J Am Acad Dermatol (2012) 0.79
[Skin cancer epidemic in the Netherlands]. Ned Tijdschr Geneeskd (2009) 0.79
Epilepsy and migraine in a patient with Urbach-Wiethe disease. Seizure (2007) 0.78
Prevalence of atopic diseases in patients with sarcoidosis. Allergy Asthma Proc (2014) 0.78
Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study. Acta Derm Venereol (2016) 0.78
Efficacy, tolerability and safety of switching from etanercept to infliximab for the treatment of moderate-to-severe psoriasis: A multicenter, open-label trial (TANGO). J Dermatolog Treat (2014) 0.78
Increased antidepressant drug exposure in psoriasis patients: a longitudinal population-based cohort study. Acta Derm Venereol (2013) 0.77
Going beyond associative studies of psoriasis and cardiovascular disease. J Invest Dermatol (2012) 0.77
A patient with xeroderma pigmentosum treated with imiquimod 5% cream. J Am Acad Dermatol (2005) 0.77
How we started performing endovenous thermal ablation procedures: a personal history. Lasers Med Sci (2014) 0.77
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol (2005) 0.76
Treatment costs of three nail lacquers used in onychomycosis. J Dermatolog Treat (2005) 0.76
Atopic dermatitis is not a protective factor for melanoma but asthma may be. Int J Clin Oncol (2013) 0.76
Letter: comment on letter to the editor. Dermatol Surg (2012) 0.75
Intense pain influences the cortical processing of visual stimuli projected onto the sensitized skin. Pain (2016) 0.75
Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefits. Arch Dermatol (2012) 0.75
Temperature measurements for dose-finding in steam ablation. J Vasc Surg (2011) 0.75
Question the obvious. Arch Dermatol (2007) 0.75
Smoking, a dangerous habit for the skin: comment on "Smoking and the risk of nonmelanoma skin cancer". Arch Dermatol (2012) 0.75
Comment on "Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides" (Cutis. 2003;71:59-61.). Cutis (2004) 0.75
Psocare: Italy shows the way in postmarketing studies. Dermatology (2008) 0.75
Insuring rapid and robust safety assessment. J Invest Dermatol (2004) 0.75
Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study. J Dermatolog Treat (2013) 0.75
Polymorphic light eruption may be associated with cigarette smoking and alcohol consumption. Photodermatol Photoimmunol Photomed (2006) 0.75
Inverse Association Between Atopy and Melanoma: A Case-control Study. Acta Derm Venereol (2017) 0.75
A phase II multicenter clinical trial of systemic bexarotene in psoriasis. J Am Acad Dermatol (2004) 0.75
Imatinib-induced eccrine squamous syringometaplasia. J Am Acad Dermatol (2006) 0.75
Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands. Drug Saf (2009) 0.75
[A man with a painful and swollen ankle]. Ned Tijdschr Geneeskd (2014) 0.75
Raman spectroscopy for cancer detection and cancer surgery guidance: translation to the clinics. Analyst (2017) 0.75
Occupational allergic contact dermatitis from bisphenol A in vinyl gloves. Contact Dermatitis (2003) 0.75
A comparative study on the efficacy of treatment with 585 nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg (2008) 0.75
[Micrographic surgery of lentigo maligna]. Ned Tijdschr Geneeskd (2016) 0.75
"Validation" of outcome measures in dermatology. J Invest Dermatol (2013) 0.75